Advertisement
Singapore markets close in 6 hours 1 minute

  • Straits Times Index

    3,161.39
    -26.27 (-0.82%)
     

  • Nikkei

    36,818.81
    -1,260.89 (-3.31%)
     

  • Hang Seng

    16,128.13
    -257.74 (-1.57%)
     

  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     

  • Bitcoin USD

    60,974.83
    -696.09 (-1.13%)
     

  • CMC Crypto 200

    1,239.71
    +354.18 (+37.00%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Gold

    2,421.40
    +23.40 (+0.98%)
     

  • Crude Oil

    86.17
    +3.44 (+4.16%)
     

  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     

  • FTSE Bursa Malaysia

    1,547.32
    +2.56 (+0.17%)
     

  • Jakarta Composite Index

    7,055.61
    -111.20 (-1.55%)
     

  • PSE Index

    6,451.76
    -71.43 (-1.09%)
     

Scholastic (SCHL) to Post Q2 Earnings: What's in the Offing?

Zacks Equity Research

Scholastic Corporation SCHL is scheduled to report second-quarter fiscal 2020 financial numbers on Dec 19, before the market opens. Notably, in the trailing four quarters, the company’s bottom line surpassed the Zacks Consensus Estimate by 6%, on average.

The Zacks Consensus Estimate for second-quarter earnings is pegged at $1.77, indicating a 15.3% decline from the year-ago quarter’s reported figure. Notably, the consensus estimate has been unchanged over the past 30 days. The consensus mark for revenues stands at $591.2 million, suggesting a 2.2% dip from the year-ago quarter’s reported figure.

Scholastic Corporation Price and EPS Surprise

 

Scholastic Corporation Price and EPS Surprise
Scholastic Corporation Price and EPS Surprise

Scholastic Corporation price-eps-surprise | Scholastic Corporation Quote

ADVERTISEMENT

Key Factors to Note

Scholastic has been focused on fair segmentation and targeting, enhanced POS devices, and automation of operational processes to schedule fairs. The company’s digital English language learning programs, which target middle-class customers, have been receiving positive consumer feedback.

Further, Scholastic has been focused on reducing inventory purchases via efficient buying and printing initiatives, and utilizing Fairs Customer Incentive programs. It remains on track with its digital transformation drive pertaining to its book clubs business in order to transit more parents and students to online ordering.

Moreover, the company has been making efforts to improve margins by undertaking pricing actions, increased promotions, better customer service and deployment of a real-time management dashboard for better analytics.

Further, management expects the international segment to have witnessed growth in trade publishing. However, any fluctuation in foreign currency might have hurt the segment’s fiscal second-quarter revenues to some extent.

What Does the Zacks Model Say?

Our proven model does not conclusively predict an earnings beat for Scholastic this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Although Scholastic carries a Zacks Rank #3, its Earnings ESP of 0.00% makes surprise prediction difficult.

Stocks to Consider

Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat.

CarMax KMX currently has an Earnings ESP of +0.21% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.

General Mills GIS has an Earnings ESP of +1.58% and a Zacks Rank #3 at present.

Amazon.com AMZN currently has an Earnings ESP of +6.74% and a Zacks Rank of 3.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CarMax, Inc. (KMX) : Free Stock Analysis Report
 
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
 
General Mills, Inc. (GIS) : Free Stock Analysis Report
 
Scholastic Corporation (SCHL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research